OmniAb Unveils OmniUltra Transgenic Chicken Platform at Virtual Investor Event

OmniAb, Inc.

OmniAb, Inc.

OABI

0.00

OmniAb Inc. will host a virtual investor event to launch its new technology platform, OmniUltra, on Monday, December 15, 2025, at 5:00 p.m. Eastern time. The event will feature a review of OmniUltra, the industry's only transgenic chicken engineered to express ultralong CDRH3 domains on a human antibody framework, and will include an overview of its market applications and strategic importance. Participants can join via webcast or phone.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OmniAb Inc. published the original content used to generate this news brief on December 04, 2025, and is solely responsible for the information contained therein.
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.